Cardinal Health

Cardinal Health (CAH) said adjusted earnings climbed 8% to 79 cents, in line with expectations. But the drug wholesaler said revenue slipped 3% to $25.9 bil as patients switched over to cheaper generics.

Cardinal Health (CAH) said adjusted earnings climbed 8% to 79 cents, in line with expectations. But the drug wholesaler said revenue slipped 3% to $25.9 bil as patients switched over to cheaper generics.

See Also

Cardinal Health (NYSE:CAH) announced Monday it was buying Johnson & Johnson's (NYSE:JNJ) cardiology and endovascular device business for $1.94 billion in cash. Cardinal, a drug wholesaler that's looking to boost its cardiovascular business, said the acquisition of Cordis would boost 2017 ...

A handful of big companies made big moves Tuesday as several Apple (NASDAQ:AAPL) chip suppliers and two pharmaceutical distributors hit new closing highs. Today's Screen of the Day features Big Cap Leaders, generally top stocks with market values of at least $15 billion priced at 15 or higher. ...

AmerisourceBergen on Wednesday reported its fastest quarterly earnings growth in more than five years, though revenue gains may continue to slow. The drug and health supplies distributor's fiscal Q1 earnings per share leaped 42.5% to $1.14, the fourth straight quarter of accelerating growth, ...

8 McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC) and Cardinal Health (NYSE:CAH) control over 85% of the distribution market, a key piece of the pharmaceutical supply chain. And as health care changes, "they are well-positioned for the evolution," an industry expert says.

Select market data is provided by Interactive Data Corp. Real Time Services. Price and Volume data is delayed 20 minutes unless otherwise noted, is believed accurate but is not warranted or guaranteed by Interactive Data Corp. Real Time Services and is subject to Interactive Data Corp. Real Time Services terms. All times are Eastern United States. *Reflects real-time index prices.